Reports for MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Brand name
MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL
Company Name
MYLAN PHARMACEUTICALS ULC
|
Drug Identification Number
02443902 |
Ingredients
EMTRICITABINE TENOFOVIR DISOPROXIL FUMARATE |
Ingredient Strength
200 MG 300 MG |
ATC Code
J05AR |
ATC Descriptor
DIRECT ACTING ANTIVIRALS |
Status
MARKETED
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Avoided shortage | 2017-09-22 | 2018-12-19 | 23172 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Resolved | 2019-01-02 | 2019-03-29 | 70748 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30 BT | Resolved | 2019-04-03 | 2019-04-23 | 80423 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30 BT | Resolved | 2019-04-23 | 2019-06-26 | 82201 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30 BT | Resolved | 2019-07-03 | 2019-07-10 | 88291 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30 BT | Resolved | 2019-07-29 | 2019-09-26 | 90113 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Avoided shortage | 2020-05-06 | 2020-05-12 | 114152 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Resolved | 2022-01-26 | 2022-02-04 | 153490 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Resolved | 2024-10-16 | 2025-04-11 | 240350 |
| MYLAN-EMTRICITABINE/TENOFOVIR DISOPROXIL | 30BT | Anticipated shortage | 2025-04-11 | 2025-04-14 | 254873 |
Showing 1 to 10 of 10
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0